The Providence South Cancer Division provides nationally accredited, cutting-edge cancer care to approximately 20,000 new patients annually. The institute provides comprehensive services spanning preventive measures to end-of-life care, advanced diagnostics, active treatments and palliative support, employing the latest medical therapies such as adoptive T cell treatments and stereotactic body radiosurgery. Emphasizing patient-centric care, treatments are tailored based on individual tumor biology, incorporating holistic factors into therapy decisions. Notably, the institute has implemented the Ambry CARE program, which offers an end-to-end solution to identify high-risk cancer patients. It also launched a pioneering multi-cancer early detection blood test. Additionally, through partnerships and innovative programs, the institute is making significant strides in reducing healthcare disparities and promoting early cancer detection. Providence South Division includes 17 hospitals throughout California, as well as many outpatient and community-based programs.
